Press Releases

2026

April 20, 2026

Associates of Cape Cod, Inc. (ACC) Achieves Major Regulatory Milestone Advancing Recombinant Endotoxin Testing
ACC Press Release

2024

August 26, 2024

Fungitell^® is awarded FDA Breakthrough Device Designation for testing of Cerebrospinal Fluid (CSF) matrix as an aid in the diagnosis of Central Nervous System (CNS) fungal infection Important Updates
ACC Press Release

August 6, 2024

With U.S. Pharmacopeia’s Approval of Chapter <86>, ACC is Positioned to Help More Biotech Companies Reduce Supply Chain Risk and Achieve Sustainability Goals
ACC Press Release

May 10, 2024

Associates of Cape Cod, Inc. (ACC) Marks 50 Years of Protection Through Detection with a New Look
ACC Press Release

2021

November 16, 2021

Associates of Cape Cod, Inc., Recipient of the Pharma Manufacturing 2021 Innovation Award for its PyroSmart NextGen^™ recombinant BET reagent
ACC Press Release

November 3, 2021

Associates of Cape Cod, Inc. Announces the Release of its One Millionth Horseshoe Crab From its Species Sustainability Project
ACC Press Release

April 23, 2021

Associates of Cape Cod, Inc. Announces Launch of PyroSmart NextGen^™ Recombinant LAL Reagent
ACC Press Release

April 22, 2021

COVID-19 and the Sustainability of the LAL Supply
Article, PDA Letter

2020

July 31, 2020

Introducing Fungitell STAT^™ a single sample test used in the diagnosis of Invasive Fungal Infections
ACC Press Release

June 15, 2020

Horseshoe crabs may be the answer to a safe coronavirus vaccine next year. Here's why.
Doug Fraser, Cape Cod Times

June 12, 2020

Horseshoe crab blood could be key to COVID-19 vaccine, expert says
Fox News